Lv13
20 积分 2025-02-28 加入
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
2小时前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
19小时前
已完结
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
20小时前
已完结
Current perspectives on the use of GLP-1 receptor agonists in obesity-related obstructive sleep apnea: a narrative review
17天前
已完结
Positive airway pressure therapy and all‐cause and cardiovascular mortality in people with obstructive sleep apnoea: a systematic review and meta-analysis of randomised controlled trials and confounder-adjusted, non-randomised controlled studies
17天前
已完结
International Classification of Sleep Disorders-Third Edition
1个月前
已关闭
International Classification of Sleep Disorders
1个月前
已完结
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
1个月前
已完结
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
1个月前
已完结
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
1个月前
已完结
皖公网安备34019202002308
